Volcanics Venture

Volcanics Venture, established in 2016, is a Shanghai-based venture capital firm with an additional office in Beijing. It focuses on investing in start-ups and growth-stage companies within the technology, media, and healthcare sectors, with a particular emphasis on internet innovation, intelligent technology, and advanced healthcare solutions driven by artificial intelligence. The firm's managing partners, Suyang Zhang, Yeshun Dong, and Ying Wu, bring over 60 years of combined VC investment and corporate management experience, providing a global perspective and local expertise to their portfolio companies. Volcanics Venture has raised a RMB fund of CNY 1.5 billion, closed in 2017, to support its investment activities.

Yeshun Dong

Founding Partner

Alicia Han

CFO

Chenhui Wang

Managing Director

Young Yang

Vice President

Zhoubo Ye

Vice President

Suyang Zhang

Managing Partner

101 past transactions

EVAS Intelligence

Series A in 2025
EVAS Intelligence is an autonomous driving chip startup. The company was founded by Liu Hui.

Unisic Technology

Series B in 2024
Unisic Technology specializes in designing and manufacturing silicon carbide core power components and semiconductor modules. The company develops a range of products utilizing third-generation silicon carbide materials, including semiconductor power modules and driver circuits. Unisic applies its silicon carbide technology across various critical sectors such as aviation, new energy power generation, high-end medical care, oil exploration, lighting, new energy vehicles, and data centers. By offering customized application solutions, Unisic Technology addresses the unique needs of its clients in these important fields, enhancing the performance and efficiency of power systems.

Unisic Technology

Venture Round in 2023
Unisic Technology specializes in designing and manufacturing silicon carbide core power components and semiconductor modules. The company develops a range of products utilizing third-generation silicon carbide materials, including semiconductor power modules and driver circuits. Unisic applies its silicon carbide technology across various critical sectors such as aviation, new energy power generation, high-end medical care, oil exploration, lighting, new energy vehicles, and data centers. By offering customized application solutions, Unisic Technology addresses the unique needs of its clients in these important fields, enhancing the performance and efficiency of power systems.

Fengtai Technology

Series B in 2023
Fengtai Technology is a company that specializes in industrial information security, focusing on providing professional and standardized safety consulting and evaluation services for chemical control. Its primary goal is to ensure the security of key industrial information infrastructures and enhance security protection solutions. Fengtai serves a diverse clientele, including government agencies, industry customers, design institutes, research organizations, integrators, and hardware and software manufacturers. The company employs visual, process-oriented, and customized tools and methods to assist users in implementing effective risk management strategies and reliable operational support. Additionally, Fengtai develops industrial control and security software solutions aimed at improving operational oversight and safety, with a strong emphasis on evaluating and designing safety guarantee systems and enterprise risk management frameworks.

GenLight Medical

Venture Round in 2023
GenLight Medical is a company based in Hangzhou, China, that specializes in developing innovative treatment solutions for epilepsy and other neurological disorders. The firm focuses on creating advanced laser medical equipment and technologies aimed at improving patient outcomes in the fields of brain science and neurosurgery. Among its notable advancements are brain-computer control technology, full-cranial implantation techniques for deep brain nerve stimulation, brain computer chips, and systems for magnetic resonance guided laser ablation, which facilitate minimally invasive surgical procedures. GenLight Medical is committed to providing high-end, technologically advanced solutions for patients requiring brain surgery.

Fabrie

Seed Round in 2022
Fabrie is a cloud-based collaboration software designed specifically for designers, focusing on enhancing team communication and idea development. The platform offers real-time synchronization, enabling multiple users to collaborate seamlessly. Fabrie is equipped with a variety of modifiable design templates, allowing users to easily start their projects without the frustration of navigating through non-editable resources. Additionally, it includes features for table and diagram associations, along with cloud storage and sharing capabilities, aimed at improving overall collaboration efficiency among design teams.

Aiagain

Series B in 2022
Aiagain provides contact module, data marketing, content radar, risk control inspection, data connection, batch labeling, automatic risk control, assets, and protecting services.

Baibaojun

Seed Round in 2022
Baibaojun is an intelligent insurance service platform that leverages artificial intelligence, big data, and cloud computing to enhance the insurance experience for consumers. The company provides users with a wealth of insurance industry news, trends, and knowledge, facilitating informed decision-making. By promoting and selling traffic, Baibaojun connects consumers with insurance consultants and teams, fostering a more efficient customer acquisition process. Through collaboration with industry partners, Baibaojun aims to innovate the traditional insurance supply and demand dynamics, shifting the focus from a sales-oriented approach to a more streamlined passive supply chain model.

Fabrie

Seed Round in 2022
Fabrie is a cloud-based collaboration software designed specifically for designers, focusing on enhancing team communication and idea development. The platform offers real-time synchronization, enabling multiple users to collaborate seamlessly. Fabrie is equipped with a variety of modifiable design templates, allowing users to easily start their projects without the frustration of navigating through non-editable resources. Additionally, it includes features for table and diagram associations, along with cloud storage and sharing capabilities, aimed at improving overall collaboration efficiency among design teams.

FlowUs

Angel Round in 2022
FlowUs is a provider of a productivity software solution designed to enhance information organization and efficiency for individuals and teams. The company offers an all-in-one platform that integrates documents, tables, folders, and instant cloud collaboration. This innovative tool serves as a centralized work center for digital information management, allowing users to seamlessly create and manage content through cloud notes, online documents, knowledge bases, and various multi-functional capabilities. By streamlining collaboration and organization, FlowUs empowers users to improve their productivity in both personal and professional settings.

Ideamake

Series C in 2022
Ideamake is a VR viewing solution provider that builds a virtual house environment through virtual reality technology. The house scene is composed of digital models of real data, follows engineering design standards and requirements, and reproduces the planned project. To help users choose the decoration style that suits them.

BOOLV

Series A in 2022
BOOLV is a software as a service (SaaS) provider specializing in AI-driven video generation, primarily catering to e-commerce businesses. The company has developed advanced technology that automates the creation of short marketing videos, utilizing big data and artificial intelligence to enhance promotional efforts. BOOLV serves a diverse clientele, including well-known brands in the fashion and furniture sectors, as well as institutions in academia and various industries. By offering a comprehensive suite of short video clips and marketing services, BOOLV aims to streamline the content creation process for overseas clothing brands and direct-to-consumer companies, fostering long-term partnerships and driving effective marketing solutions.

Enze Kangtai

Series A in 2022
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic products and exosome research.

Yunli Smart Technology

Series A in 2021
Yunli Wisdom is a digital transformation service provider for government and enterprises. It uses cloud computing, big data, Internet of Things, artificial intelligence, and blockchain as its core technologies. It focuses on government affairs, finance, transportation, manufacturing, ecological environment and other fields, and is committed to providing Application software and services empowered by new technologies.

Alluxio

Series C in 2021
Alluxio, Inc. is a technology company based in Berkeley, California, founded in 2015. It specializes in a memory-centric distributed storage system that facilitates unified data access across various storage systems. Originally known as Tachyon Nexus, the company is closely associated with an open-source project developed at UC Berkeley's AMPLab. Alluxio's platform enables organizations to perform analytics and machine learning in the cloud by moving data closer to the compute frameworks, thus providing memory-speed access to files and objects. This innovative approach primarily serves customers in sectors such as financial services, retail, and telecommunications, helping them achieve consistent performance in their data management processes. The company also collaborates strategically with Intel to enhance its offerings.

Thinktech

Series A in 2021
Thinktech is a design and manufacturing company that specializes in producing automotive-grade semiconductors. They provide automotive security designed for ICV applications with built-in hardware. The company focuses on providing comprehensive security solutions to the Chinese automotive sector.

Space Transportation

Venture Round in 2021
Space Transportation is a company focused on designing and manufacturing space transport systems that aim to lower the costs associated with space exploration. The firm specializes in the development of reusable commercial space transport vehicles, which are intended to significantly reduce commercial launch expenses by addressing challenges related to reentry and vehicle recycling. Through its innovative approach, Space Transportation seeks to enhance the efficiency and affordability of space missions, contributing to the growth of the commercial space industry.

BaishanCloud

Venture Round in 2021
BaishanCloud, founded in April 2015, is a provider of cloud-managed services that focuses on cloud resource exchanges and interactions. The company offers a comprehensive suite of services, including cloud delivery, cloud storage, and cloud linkages, designed to meet the diverse needs of enterprise customers. BaishanCloud emphasizes data governance and utilizes analytics-driven security policies and intelligent caching algorithms to ensure the security of data in transit. Its cloud management platform facilitates data migration, integration, acceleration, and analytics, effectively supporting clients in navigating multi-cloud infrastructures. With its innovative approach, BaishanCloud aims to enhance the efficiency and effectiveness of cloud services for businesses.

Huleen

Angel Round in 2021
Huleen is committed to opening up application boundaries and bringing together more information.

Dynasty Gene

Series A in 2021
Dynasty Gene is a developer of synthetic biology technology that offers biotechnology consulting services, primarily focused on advancing next-generation DNA sequencing (NGS). The company specializes in technology development, consulting, transfer, and technical services within the biotechnology sector. It holds independent intellectual property rights for its Micropore high-throughput DNA synthesis platform, which enables the launch of various products such as liquid biopsy solutions and NGS library capture kits. Through its innovative approaches and proprietary technologies, Dynasty Gene aims to support clients in achieving significant advancements in genetic analysis and related fields.

Zenlayer

Series C in 2021
Zenlayer Inc. is a technology company based in Diamond Bar, California, specializing in global connectivity solutions for enterprises. Founded in 2014, Zenlayer provides a software-defined network and services that include bare metal cloud, SD-WAN cloud connect, edge computing, and colocation services across more than 100 data centers on six continents. Its platform allows businesses to deploy and manage IT resources efficiently, enhancing digital experiences and reducing latency. By leveraging Zenlayer's services, enterprises can achieve instant worldwide connectivity, facilitating smoother operations and improved user experiences.

Phanes Therapeutics

Series B in 2021
Phanes Therapeutics, Inc. is a biotechnology company based in San Diego, California, established in 2016. It specializes in drug discovery and early development in the fields of immuno-oncology and eye diseases. The company is developing a range of therapeutic molecules, including monoclonal antibodies targeting solid tumors and conditions such as age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. In addition, Phanes Therapeutics is working on bispecific antibodies aimed at treating small cell lung cancer. With a strong foundation in scientific knowledge and innovation, the company is committed to advancing effective treatment options and improving patient outcomes on a global scale.

Alpha Cen

Seed Round in 2021
Alpha Cen is a developer of wafer-level metasurface light control chips and modules. It offers a semiconductor IC-compatible process to integrate micro-nano optical metasurfaces with circuits, light sources, and photodetectors.

Koka Lifesciences

Venture Round in 2021
Koka Lifesciences is a company dedicated to the research, development, production, and distribution of medical devices specifically designed for structural heart disease. It specializes in heart valve interventional devices, including valves and valve repair machinery. By focusing on innovative solutions, Koka Lifesciences aims to enhance surgical outcomes by reducing operation time and improving success rates for patients undergoing procedures related to structural heart conditions. The company combines advanced technology with a commitment to addressing the challenges within the field of cardiology.

Hexcloud

Series A in 2020
Hexcloud is the next generation of retail digital middle end technology. Their products include a platform as a service, an omni channel fulfillment platform, a global marketing center, and a store supply chain platform. Hexcloud platform integrates retail chain store operational data covering sales, supply chain, and finance and offers centralized business intelligence for retail stores.

Vision Medicals Technology

Series B in 2020
Vision Medicals Technology is a provider of advanced diagnostic services specializing in pathogenic gene detection. The company focuses on infection-precise medical treatment and employs high-throughput sequencing-based pathogen metagenomics, CRISPR-based rapid diagnosis, and other innovative technologies. By enhancing the detection capabilities for clinical pathogens, Vision Medicals aims to shorten reporting cycles and accelerate the development of the infection-accurate medical sector. It has developed proprietary pathogenic nucleic acid enrichment technology to detect micronucleic acids in clinical samples. The company leverages extensive big data in pathogen detection, supported by its genomics intelligent analysis and reporting system, to deliver precise and efficient medical diagnostics to its clients.

Brite Semiconductor

Series D in 2020
Brite Semiconductor, Inc. is a custom design and manufacturing company specializing in system-on-chip (SoC) and application-specific integrated circuit (ASIC) solutions. Founded in 2008 and headquartered in Shanghai, China, the company focuses on creating tailored silicon solutions by integrating advanced intellectual property (IP), foundry, test, and packaging technologies. Brite offers a comprehensive suite of services, including turnkey solutions, supply chain management, manufacturing engineering, and quality assurance. Their YouIP portfolio, which encompasses branches like YouPHY, YouRF, and YouSiP, is designed to expedite product development from specification to silicon, enhancing delivery rates and reducing time to market. With a commitment to quality and customer-centric service, Brite Semiconductor aims to meet diverse ASIC needs while minimizing risks associated with design and production processes. The company's innovative MAX technology further optimizes costs and yields for advanced semiconductor designs, establishing Brite as a reliable partner in the ASIC industry.

Cloudpick

Series A in 2020
Cloudpick Technology is a high-tech enterprise focused on developing computer vision and artificial intelligence applications, particularly for the retail sector. The company is dedicated to advancing core AI technologies and creating comprehensive solutions for artificial intelligence and big data analysis across various industries. Cloudpick has developed a patented behavior recognition and product learning algorithm that accurately identifies product information and customer shopping behaviors. This innovation enables seamless shopping experiences, such as "Grab and Go" and senseless payment systems, enhancing convenience for consumers in smart retail environments.

Polaris Biology

Series B in 2020
Polaris Biology is a medical technology company focused on the development and application of cell-level precision diagnostic technology aimed at enhancing tumor diagnosis and treatment. The company employs advanced artificial intelligence algorithms and drug-system biological models to deliver accurate and direct clinical support for cancer treatment. By investigating individual and dynamic changes in tumors at the cellular level, Polaris Biology provides innovative diagnostic tools that assist both patients and healthcare professionals in making informed decisions regarding cancer care.

Deep Mirror

Seed Round in 2020
Deep Mirror is a startup developing state-of-the-art spatial intelligence technology and creating a multi-layer digital twin of the real world. It offers competitive rewards, equal promotion opportunities, and access to the most cutting-edge technology towards spatial intelligence.

Alluxio

Series B in 2020
Alluxio, Inc. is a technology company based in Berkeley, California, founded in 2015. It specializes in a memory-centric distributed storage system that facilitates unified data access across various storage systems. Originally known as Tachyon Nexus, the company is closely associated with an open-source project developed at UC Berkeley's AMPLab. Alluxio's platform enables organizations to perform analytics and machine learning in the cloud by moving data closer to the compute frameworks, thus providing memory-speed access to files and objects. This innovative approach primarily serves customers in sectors such as financial services, retail, and telecommunications, helping them achieve consistent performance in their data management processes. The company also collaborates strategically with Intel to enhance its offerings.

Hannto Technology

Series B in 2020
Hannto Technology Inc. is a Shanghai-based company established in 2017 that specializes in the development of smart devices, Internet of Things (IoT) applications, and image output products and services. The company is particularly known for its mobile photo printer, XPRINT, which allows users to print directly from their mobile devices. Hannto Technology emphasizes design, research and development, and manufacturing of intelligent hardware, focusing on enhancing the consumer printing experience. By deeply engaging with industries and understanding user preferences, the company aims to create high-quality products that cater to consumers' printing habits and needs.

RootPath Genomics

Series A in 2020
RootPath Genomics, Inc. is a biotechnology company founded in 2017 and headquartered in Cambridge, Massachusetts. The company specializes in developing a next-generation T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of individual immune cells, RootPath aims to enhance immune responses and improve cell therapy efficacy. Its innovative technologies allow for precise monitoring and modulation of the immune system, which is intended to revolutionize the diagnosis and treatment of cancer.

Saints & Sages

Venture Round in 2020
Saints & Sages Medical specializes in the development and production of minimally invasive surgical medical devices. The company offers a range of energy devices that are utilized across various medical fields, including hepatobiliary, gynecology, urology, thoracic surgery, thyroid and breast surgery, and gastrointestinal surgery. With a commitment to addressing clinical needs, Saints & Sages focuses on innovation in surgical technology. They leverage a dedicated research and development team and extensive clinical experience to create devices that enhance the precision and efficiency of surgical procedures, ultimately aiming to improve patient outcomes globally.

Space Transportation

Seed Round in 2019
Space Transportation is a company focused on designing and manufacturing space transport systems that aim to lower the costs associated with space exploration. The firm specializes in the development of reusable commercial space transport vehicles, which are intended to significantly reduce commercial launch expenses by addressing challenges related to reentry and vehicle recycling. Through its innovative approach, Space Transportation seeks to enhance the efficiency and affordability of space missions, contributing to the growth of the commercial space industry.

CaiCloud

Series B in 2019
Caicloud is a private company based in Hangzhou, China, founded in July 2015, specializing in cloud computing. The company has developed an advanced Kubernetes-based Cluster-as-a-Service (CaaS) platform, which includes enhanced cluster management features such as security management, DevOps capabilities, application orchestration, and troubleshooting intelligence. This platform is designed to integrate with public clouds in China and on-premise infrastructures like VMware and OpenStack, catering to the needs of enterprise clients, including Fortune 500 companies. Additionally, Caicloud offers a TensorFlow-as-a-Service (TaaS) solution that operates on their CaaS platform, enabling functionalities like automatic anomaly detection and service lifecycle management, as well as industry-specific AI solutions. Beyond its commercial offerings, Caicloud actively contributes to the Kubernetes community, having open-sourced various plugins and tools, including a Kubernetes-native CI/CD project named Cyclone.

Eoitek Technology

Series B in 2019
Eoitek Technology is a provider of intelligent big data analysis solutions, established in 2014 and headquartered in Shanghai, China. The company specializes in AIOps, a self-developed product that effectively collects, processes, analyzes, and displays multi-dimensional operational data, including fault events, performance metrics, and various logs. Eoitek's solutions are designed to assist enterprises in various sectors such as banking, insurance, manufacturing, energy, and transportation by leveraging artificial intelligence and big data technologies to uncover the value of their operational data and support digital transformation initiatives. The company offers its services through both onsite deployments and a subscription model, ensuring flexibility for its clients in accessing critical data insights.

Naxions

Series B in 2019
Beijing Naxions Technology Co., Ltd. specializes in providing digital marketing services tailored for the medical Internet industry. Founded in 2014 and headquartered in Chaoyang District, China, with additional offices in Shanghai, the company has developed a communication software solution that incorporates a SaaS platform. This platform enables real-time data analysis, project management, and customer insights while streamlining processes such as data capture, collection, scraping, cleaning, calculation, and presentation. Naxions focuses on enhancing efficiency for pharmaceutical companies by leveraging advanced semantic understanding and deep learning algorithms to improve sales management and bolster brand image through innovative internet technologies.

Beijing Gene+ Technology

Series B in 2019
Beijing Gene+ Technology, founded in 2015 and based in Beijing, China, specializes in gene testing services aimed at cancer prevention and early detection. The company provides a range of services, including clinical testing, medical device manufacturing, and scientific cooperation related to precision medicine. Operating in approximately 100 hospitals, Beijing Gene+ Technology has supported thousands of cancer patients across the country, contributing to advancements in personalized healthcare and tumor treatment strategies.

Ruixun Biotech

Series A in 2019
Ruixun Biotech is a healthcare company that provides biotechnology. Ruixun Biotech combines microfluidics, optics, precision instruments, electronic engineering, and biochemical technologies to create upstream equipment and consumables for molecular diagnosis and genetic testing. They released a number of products, including the digital PCR apparatus DropX-2000 and more than 50 different RUO detection kits.

RainSure Scientific

Series A in 2019
RainSure Scientific is a medical-based manufacturing company that produces PCR instruments, assays, and healthcare services.

Vision Medicals Technology

Series A in 2019
Vision Medicals Technology is a provider of advanced diagnostic services specializing in pathogenic gene detection. The company focuses on infection-precise medical treatment and employs high-throughput sequencing-based pathogen metagenomics, CRISPR-based rapid diagnosis, and other innovative technologies. By enhancing the detection capabilities for clinical pathogens, Vision Medicals aims to shorten reporting cycles and accelerate the development of the infection-accurate medical sector. It has developed proprietary pathogenic nucleic acid enrichment technology to detect micronucleic acids in clinical samples. The company leverages extensive big data in pathogen detection, supported by its genomics intelligent analysis and reporting system, to deliver precise and efficient medical diagnostics to its clients.

Furrytail

Series A in 2019
Furrytail is a designer and manufacturer of innovative pet lifestyle products, focusing on enhancing the quality of life for pets through modern, minimalist designs. The company specializes in a range of offerings, including pet clothing, cat sleepers, food bowls, and cat mints, all aimed at providing affordable yet high-quality solutions for pet owners. By targeting the youngest cat population, Furrytail seeks to build a strong brand presence and capture market share by addressing the full life cycle value of cat ownership. The company's approach emphasizes understanding consumer demands and integrating channel advantages to foster a dedicated cultural consumer group around its products.

Dynasty Gene

Series A in 2019
Dynasty Gene is a developer of synthetic biology technology that offers biotechnology consulting services, primarily focused on advancing next-generation DNA sequencing (NGS). The company specializes in technology development, consulting, transfer, and technical services within the biotechnology sector. It holds independent intellectual property rights for its Micropore high-throughput DNA synthesis platform, which enables the launch of various products such as liquid biopsy solutions and NGS library capture kits. Through its innovative approaches and proprietary technologies, Dynasty Gene aims to support clients in achieving significant advancements in genetic analysis and related fields.

Zenlayer

Series B in 2019
Zenlayer Inc. is a technology company based in Diamond Bar, California, specializing in global connectivity solutions for enterprises. Founded in 2014, Zenlayer provides a software-defined network and services that include bare metal cloud, SD-WAN cloud connect, edge computing, and colocation services across more than 100 data centers on six continents. Its platform allows businesses to deploy and manage IT resources efficiently, enhancing digital experiences and reducing latency. By leveraging Zenlayer's services, enterprises can achieve instant worldwide connectivity, facilitating smoother operations and improved user experiences.

Fourier Intelligence

Series B in 2019
Fourier Intelligence is a Shanghai-based technology and design company that specializes in the development of exoskeleton robotic products and services aimed at rehabilitation and orthoses. The company offers advanced robotics technology, including upper-limb rehabilitation robotics and lower-limb exoskeletons, which assist individuals with disabilities in overcoming physical limitations, enabling them to stand and walk again. Its innovative products not only enhance the quality of life for users but also improve productivity by reducing fatigue and facilitating the transportation of heavy objects in various sectors. Fourier Intelligence is committed to advancing healthcare and rehabilitation through its pioneering technologies, empowering individuals to regain mobility and independence.

AIMON

Series C in 2019
Aimon is a designer and manufacturer based in Shanghai, China, specializing in cartoon and animation products. The company focuses on developing cultural and creative derivatives, offering a range of products including toy models, clothing, office stationery, suitcases, and daily consumables. Aimon collaborates with well-known animation brands from Japan and Taiwan, acquiring intellectual property rights from original creators to produce corresponding merchandise for anime enthusiasts. Through its diverse product offerings, Aimon aims to cater to the growing demand for animation-related items in both domestic and international markets.

OncXerna Therapeutics

Series B in 2019
OncXerna Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for cancer patients by utilizing an RNA-based biomarker platform. The company aims to improve patient outcomes by prospectively identifying individuals based on the unique RNA biology of their tumor microenvironments. This innovative approach enables OncXerna to match patients with targeted oncology therapies that correspond to their specific tumor characteristics. Founded in 2018 and based in Waltham, Massachusetts, with an additional location in Shanghai, China, OncXerna was formerly known as Oncologie, Inc. and changed its name in September 2020 to reflect its commitment to advancing next-generation precision medicine for a broader range of cancer patients.

LenoMed Medical

Series C in 2019
LenoMed Medical is a manufacturer of medical devices focused on improving diabetes management. With over 15 years of research and development experience in infusion technology, the company specializes in creating innovative products such as the InnoTech insulin pump, drug infusion pumps, and related disposables. LenoMed is dedicated to enhancing diabetes care through the integration of continuous glucose monitoring technology with their insulin pumps, aiming to provide patients with better treatment options and monitoring capabilities. Their commitment to advancing diabetes management is reflected in their comprehensive diabetes care management system.

SpaceTouch

Series A in 2019
SpaceTouch, established by a group of electrical engineering professors and doctors from Princeton University, specializes in the development of advanced 3D gesture interfaces. With a strong focus on human-computer interaction, the company has positioned itself as a leading provider of core chips and solutions for integrated circuits. Its innovative technology utilizes non-touch air gesture recognition algorithms based on capacitive sensing, allowing users to interact with their devices through intuitive air gestures. This capability enables developers to create applications across various sectors, including consumer electronics, wearable devices, digital signage, smart furniture, and the automotive industry.

Polaris Biology

Series A in 2019
Polaris Biology is a medical technology company focused on the development and application of cell-level precision diagnostic technology aimed at enhancing tumor diagnosis and treatment. The company employs advanced artificial intelligence algorithms and drug-system biological models to deliver accurate and direct clinical support for cancer treatment. By investigating individual and dynamic changes in tumors at the cellular level, Polaris Biology provides innovative diagnostic tools that assist both patients and healthcare professionals in making informed decisions regarding cancer care.

eMeet

Venture Round in 2019
eMeet is a company that specializes in developing advanced conferencing devices aimed at enhancing audio performance during voice collaborations. The company has designed its first professional speakerphone, incorporating an AI-driven noise reduction algorithm. eMeet's products utilize a sophisticated voice interface that integrates background noise and echo suppression, alongside artificial intelligence for sound capture and automatic volume adjustment. This technology allows users to filter human voices and effectively minimize background noise, ensuring clear and natural two-way conversations even in challenging acoustic environments.

Aiqi Technology

Series B in 2018
Beijing AIQI Technology Co., Ltd. is an Internet technology company focused on the research and development of artificial intelligence and robotic technologies. The company has assembled a dynamic team of innovative and ambitious individuals dedicated to advancing the field. Over the past three years, Aiqi Technology has secured numerous patents related to intelligent equipment. It has established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. The company specializes in the development of interactive DIY family robots designed for K-12 STEM education, offering users engaging human-machine interaction experiences. With a strong research team and advanced technology, Aiqi Technology aims to inspire creativity and provide enjoyable, easy-to-use products that enhance modern life.

Furrytail

Seed Round in 2018
Furrytail is a designer and manufacturer of innovative pet lifestyle products, focusing on enhancing the quality of life for pets through modern, minimalist designs. The company specializes in a range of offerings, including pet clothing, cat sleepers, food bowls, and cat mints, all aimed at providing affordable yet high-quality solutions for pet owners. By targeting the youngest cat population, Furrytail seeks to build a strong brand presence and capture market share by addressing the full life cycle value of cat ownership. The company's approach emphasizes understanding consumer demands and integrating channel advantages to foster a dedicated cultural consumer group around its products.

Geek+

Series B in 2018
Geek+ is a developer of autonomous mobile robots aimed at enhancing automation in warehouses, factories, and supply chain management. The company leverages advanced robotics and artificial intelligence technologies to offer flexible and intelligent logistics solutions tailored to various industries, including e-commerce, retail, logistics, pharmaceuticals, and manufacturing. Geek+ has established itself as a leader in the logistics robotics market in China, having delivered a significant number of robots compared to its competitors. Its clientele includes e-commerce platforms, third-party logistics providers, and manufacturers across diverse sectors such as apparel, electronics, and automotive. Additionally, Geek+ collaborates with key customers to co-create customized AI and robotic solutions, ensuring that they meet specific operational needs while providing reliable products and high-quality after-sales services.

Urban Fable Basketball Club (Beijing)

Series A in 2018
Urban Fable Basketball Club (Beijing) is a sports company focused on promoting basketball enjoyment among a diverse audience. The club provides a comprehensive array of professional events and services, both online and offline, aimed at facilitating access to the sport. By creating engaging experiences, Urban Fable Basketball Club encourages basketball enthusiasts to participate and share their passion for the game with friends, fostering a vibrant community centered around basketball.

GJS Robot

Series B in 2018
GJS Robot specializes in the development of consumer battle robots and gaming robots that leverage artificial intelligence and advanced technology. The company designs customized fighting robots intended for competition, incorporating features such as servo motors and wheels. Their products are equipped with infrared cameras and deep learning capabilities, allowing for enhanced performance and man-machine synchronization control. Through its innovative approach, GJS Robot aims to provide clients with cutting-edge robotic solutions for engaging in robot combat competitions.

RootPath Genomics

Seed Round in 2018
RootPath Genomics, Inc. is a biotechnology company founded in 2017 and headquartered in Cambridge, Massachusetts. The company specializes in developing a next-generation T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of individual immune cells, RootPath aims to enhance immune responses and improve cell therapy efficacy. Its innovative technologies allow for precise monitoring and modulation of the immune system, which is intended to revolutionize the diagnosis and treatment of cancer.

Shebaotong

Series B in 2018
Shebaotong provides social security, provident fund, commercial insurance, salary services, labor cost optimization and other services.

Maia Active

Series A in 2018
Maia Active is an athleisure sportswear brand that specializes in designing and manufacturing sportswear for Asian girls. The company focuses on creating stylish and functional clothing that enhances the experience of physical activity. By prioritizing comfort and motivation, Maia Active aims to provide sportswear that meets both aesthetic and practical needs, allowing customers to feel confident and empowered while engaging in sports and fitness activities.

Ruixun Biotech

Seed Round in 2018
Ruixun Biotech is a healthcare company that provides biotechnology. Ruixun Biotech combines microfluidics, optics, precision instruments, electronic engineering, and biochemical technologies to create upstream equipment and consumables for molecular diagnosis and genetic testing. They released a number of products, including the digital PCR apparatus DropX-2000 and more than 50 different RUO detection kits.

ImageDT

Series A in 2018
ImageDT is an enterprise services company specializing in image recognition and semantic analysis technology. Its innovative solutions enable businesses to leverage fast product modeling, accurate recognition, and comprehensive data collection. ImageDT's technology supports offline inventory management and e-commerce monitoring, as well as providing insights into online public opinion. By delivering precise information and instant reports, the company empowers brands to identify growth opportunities and gain a competitive edge in the market.

IPSTAR

Seed Round in 2018
IPSTAR is a Media & Entertainment Start up.

Aiagain

Series A in 2018
Aiagain provides contact module, data marketing, content radar, risk control inspection, data connection, batch labeling, automatic risk control, assets, and protecting services.

OncXerna Therapeutics

Seed Round in 2018
OncXerna Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for cancer patients by utilizing an RNA-based biomarker platform. The company aims to improve patient outcomes by prospectively identifying individuals based on the unique RNA biology of their tumor microenvironments. This innovative approach enables OncXerna to match patients with targeted oncology therapies that correspond to their specific tumor characteristics. Founded in 2018 and based in Waltham, Massachusetts, with an additional location in Shanghai, China, OncXerna was formerly known as Oncologie, Inc. and changed its name in September 2020 to reflect its commitment to advancing next-generation precision medicine for a broader range of cancer patients.

Sandieji

Series A in 2018
A Medical technology Company based in Nanjing,China.

Triastek

Series A in 2018
Triastek Co. Ltd., established in 2015 and headquartered in Nanjing, China, specializes in the manufacturing of 3D printed pharmaceuticals and related medical equipment. The company offers a range of drugs, including blockbuster and orphan drugs, along with complex drug delivery technologies. Triastek's portfolio includes 3D drug printing services, such as formulation design, equipment, and development methods, with patents secured in key global markets like China, the US, Europe, and Japan. Notably, the company owns Melt Extrusion Deposition (MED), a universally applicable 3D printing technology for solid formulations. Triastek's mission is to revolutionize drug delivery, development, and manufacturing through its proprietary 3D printing technology.

YingLink

Series A in 2018
YingLink is a company focused on enhancing the grading and diagnosis of medical products through its innovative cloud-based platform. This platform is designed to assist radiologists by facilitating better communication, improving diagnostic knowledge, and enhancing medical imaging skills, all while enabling remote work capabilities. By leveraging technology, YingLink aims to streamline the diagnostic process and support healthcare professionals in their efforts to deliver accurate and timely medical assessments.

XPECT Vision

Series B in 2018
Founded in 2015, Xpect Vision Technology is a high-tech company specializing in the development of innovative imaging technology, particularly photon-counting X-ray imaging. The company manufactures medical imaging chips designed for the medical detection and service industry, utilizing advanced digital X-ray imaging technology and CMOS X-ray detection methods. These imaging chips are integrated into medical electronic products, enabling physicians to enhance the accuracy of cancer diagnoses and improve overall efficiency in medical services. Xpect Vision is positioned to lead future developments in high-speed and high-definition imaging solutions.

Innovative Cellular Therapeutics

Series B in 2018
Innovative Cellular Therapeutics Co., Ltd. is a biotechnology company based in Shanghai, China, that specializes in the research and development of cell therapy. Established in 2009, the company focuses on creating chimeric antigen receptor T (CAR-T) products aimed at treating both blood cancers and solid tumors. Its development program includes innovative approaches such as allogeneic CAR-T therapies using gene editing and gene therapy techniques. Innovative Cellular Therapeutics is dedicated to advancing cellular immunotherapies that target late-stage solid tumors, including colorectal and thyroid cancers, with the goal of improving patient outcomes and supporting healthier lives.

Eoitek Technology

Series A in 2018
Eoitek Technology is a provider of intelligent big data analysis solutions, established in 2014 and headquartered in Shanghai, China. The company specializes in AIOps, a self-developed product that effectively collects, processes, analyzes, and displays multi-dimensional operational data, including fault events, performance metrics, and various logs. Eoitek's solutions are designed to assist enterprises in various sectors such as banking, insurance, manufacturing, energy, and transportation by leveraging artificial intelligence and big data technologies to uncover the value of their operational data and support digital transformation initiatives. The company offers its services through both onsite deployments and a subscription model, ensuring flexibility for its clients in accessing critical data insights.

TRON

Angel Round in 2018
TRON is a technology company founded in 2017 and based in Shanghai, China, with an additional office in California. The company specializes in the development of artificial intelligence technology aimed at enhancing third-level and fourth-level autopilot functions within the automotive sector. By focusing on the automobile engine control unit (ECU), TRON aims to address key challenges in the vehicle driving market, providing innovative solutions that improve the capabilities of automatic driving systems.

Aishen Medical

Series A in 2018
Aishen Medical (爱肾医疗) is a SaaS-based platform that offers kidney disease management services, particularly for patients with chronic kidney diseas. It focuses on the provision of popular science and chronic disease management services for patients with kidney disease.

Ishen365

Series A in 2018
Ishen365 is a Shanghai-based company that specializes in developing and operating a renal care service platform tailored for the healthcare sector. The company focuses on providing comprehensive chronic disease management solutions specifically designed for patients with kidney disease. Through its platform, Ishen365 offers medical services aimed at treating kidney conditions and other chronic illnesses, ensuring that clients receive effective clinical management for various renal diseases.

Dadao

Series B in 2018
Car sharing platform

Genus Finance

Series A in 2018
Genus Finance, founded in 2015 and based in Shanghai, China, is a quantitative investment and technology trading platform that specializes in algorithmic trading tools and services. The company offers a range of algorithmic trading strategies designed to enhance the efficiency and effectiveness of financial transactions for investment institutions, including public funds, private equity, and securities firms. Its product lineup features various algorithms, such as G-TWAP, G-VWAP, G-Percent, G-PxlnLine, G-Sniper, and G-DMA+, each tailored to optimize order execution based on specific market conditions and investor needs. Genus Finance is dedicated to providing safe, efficient, and cost-effective trading solutions that cater to the evolving demands of the financial investment landscape.

Fourier Intelligence

Series A in 2018
Fourier Intelligence is a Shanghai-based technology and design company that specializes in the development of exoskeleton robotic products and services aimed at rehabilitation and orthoses. The company offers advanced robotics technology, including upper-limb rehabilitation robotics and lower-limb exoskeletons, which assist individuals with disabilities in overcoming physical limitations, enabling them to stand and walk again. Its innovative products not only enhance the quality of life for users but also improve productivity by reducing fatigue and facilitating the transportation of heavy objects in various sectors. Fourier Intelligence is committed to advancing healthcare and rehabilitation through its pioneering technologies, empowering individuals to regain mobility and independence.

Polaris Biology

Seed Round in 2018
Polaris Biology is a medical technology company focused on the development and application of cell-level precision diagnostic technology aimed at enhancing tumor diagnosis and treatment. The company employs advanced artificial intelligence algorithms and drug-system biological models to deliver accurate and direct clinical support for cancer treatment. By investigating individual and dynamic changes in tumors at the cellular level, Polaris Biology provides innovative diagnostic tools that assist both patients and healthcare professionals in making informed decisions regarding cancer care.

Polaris Technology

Seed Round in 2018
Polaris Technology i provides biomedical research institutes with cloud services of computational visualization and analysis specific to heterogeneous biomedical data. Our services are delivered to stakeholders through cloud-based deep learning models, cross-platform interactive data analysis systems, and crowd-sourcing data platforms.

Shanghai STEM Cloud

Series A in 2018
Shanghai STEM Cloud is a company dedicated to enhancing Science, Technology, Engineering, and Mathematics (STEM) education. It collaborates with professional societies, associations, and research institutions to integrate both domestic and international educational resources. The company provides online classes, tools, labs, and competitions aimed at improving STEM learning for educational institutions and individuals. Additionally, Shanghai STEM Cloud offers professional training to uncover new possibilities in teaching and research within the STEM field.

Lingyi Zhihui

Venture Round in 2018
Zuoshouyisheng's AI ​​doctor platform spans 35 medical specialties and can diagnose more than 6,000 diseases, according to the company’s website. Zuoshouyisheng mainly collaborates with customers through a SaaS business model, providing its AI-empowered healthcare system to hospitals, pharmaceutical companies, employers, and insurers.

Senslab

Venture Round in 2018
Senslab is a technology company specializing in the development of artificial intelligence solutions. It focuses on creating visual appliances that incorporate AI technology, including products such as face recognition cameras, intelligent security cameras, and smart doorbells. These offerings are designed to provide enterprises with low-power and cost-effective security options, making advanced AI products more accessible to a wider audience. Senslab aims to enhance security through innovative technology while ensuring affordability and efficiency for its users.

Geneplus-Beijing

Venture Round in 2018
Geneplus Co.,Ltd. is a market leader in biotechnology and molecular diagnostic distribution. The company is primarily concerned with molecular biological solutions for Applied Life Science and Molecular Diagnostics.

IPMBiotech

Venture Round in 2018
IPMBiotech focuses on the development and application of precision medical technology and cell therapy technology.

Future Vision

Venture Round in 2018
Future Vision is a visual health service organization based in Shanghai, specializing in the prevention and control of myopia, amblyopia rehabilitation training, and medical optometry for children aged 3 to 16. The company utilizes advanced North American optometry technology to deliver its services, aiming to address the growing concerns of visual health among children. By focusing on early intervention and comprehensive eye care, Future Vision seeks to improve the visual outcomes for its young clientele.

WeShine

Series B in 2017
WeShine is a Chinese platform specializing in the sharing of GIF images and video content. The service has reached over 800 million users across China, establishing a significant presence in the market with a reported market share of over 90% in the GIF search engine sector. WeShine offers a user-friendly interface that enables individuals to easily search for and share popular visual content, making it a prominent player in the digital media landscape.

Health Biotech

Angel Round in 2017
Health Biotech is a research and development firm focused on precision medicine through the application of mass spectrometry technology. The company specializes in creating comprehensive detection solutions that include tools, equipment, and reagent consumables. Its innovative technology employs liquid chromatography-mass spectrometry to facilitate the early diagnosis, treatment, and monitoring of Alzheimer's disease. By quantitatively detecting specific biomarkers, such as "ipilin," Health Biotech enables healthcare professionals to assess Alzheimer's risk and provide targeted interventions aimed at delaying disease onset and enhancing cognitive function in patients. Through its commitment to advancing mass spectrometry applications, Health Biotech strives to deliver reliable services and improve patient outcomes in the realm of neurological health.

Keyin Tech

Series A in 2017
Keyin Tech is a technology and service research and development enterprise specializing in the medical field. The company focuses on physical robotics and cloud technology platforms, offering innovative solutions designed to enhance surgical procedures and patient care. Keyin Tech develops virtual reality solutions aimed at improving surgical planning, clinical analysis, and rehabilitation training. Their primary systems include a pre-surgery platform for planning, a surgery navigator, and robotics specifically designed for surgical applications. These advancements enable surgeons to improve communication with patients and reduce the likelihood of surgical accidents, thereby contributing to safer and more effective medical practices.

Geek+

Series B in 2017
Geek+ is a developer of autonomous mobile robots aimed at enhancing automation in warehouses, factories, and supply chain management. The company leverages advanced robotics and artificial intelligence technologies to offer flexible and intelligent logistics solutions tailored to various industries, including e-commerce, retail, logistics, pharmaceuticals, and manufacturing. Geek+ has established itself as a leader in the logistics robotics market in China, having delivered a significant number of robots compared to its competitors. Its clientele includes e-commerce platforms, third-party logistics providers, and manufacturers across diverse sectors such as apparel, electronics, and automotive. Additionally, Geek+ collaborates with key customers to co-create customized AI and robotic solutions, ensuring that they meet specific operational needs while providing reliable products and high-quality after-sales services.

Xiaodupi

Series C in 2017
Xiaodupi is a developer of mobile applications focused on social engagement and personal development for younger audiences. The company's notable product is the Little Belly app, a weight loss application that leverages health technology to synchronize user weight data and provide personalized weight loss plans. Additionally, Xiaodupi has created a social media and gaming platform designed for girls under fourteen, which gamifies career learning and social development. This platform encourages interaction by offering virtual fashion items as incentives, fostering an engaging environment for its users. Through these applications, Xiaodupi aims to combine health management and social interaction in innovative ways.

Geek+

Series A in 2017
Geek+ is a developer of autonomous mobile robots aimed at enhancing automation in warehouses, factories, and supply chain management. The company leverages advanced robotics and artificial intelligence technologies to offer flexible and intelligent logistics solutions tailored to various industries, including e-commerce, retail, logistics, pharmaceuticals, and manufacturing. Geek+ has established itself as a leader in the logistics robotics market in China, having delivered a significant number of robots compared to its competitors. Its clientele includes e-commerce platforms, third-party logistics providers, and manufacturers across diverse sectors such as apparel, electronics, and automotive. Additionally, Geek+ collaborates with key customers to co-create customized AI and robotic solutions, ensuring that they meet specific operational needs while providing reliable products and high-quality after-sales services.

Jianke

Series A in 2017
Guangdong Jianke Pharmaceutical Co., Ltd. operates a network of nine pharmacy stores and an online retail platform in China. Established in 2006 and based in Dongguan, the company offers a diverse range of products, including medications for hepatobiliary, dermatology, pediatric, and urology conditions, as well as treatments for digestive, nervous, and respiratory systems. Jianke also provides female health medication, health care products, medical instruments, and beauty care items. The company focuses on addressing the needs of patients with chronic diseases through its online chronic disease management services, which complement its pharmacy offerings. Its primary revenue stream comes from online retail pharmacy services, supplemented by comprehensive medical services and tailored marketing solutions.

Xiao Dengta

Series A in 2017
Xiao Dengta provides career advancement and career development solutions.

Manhuadao

Series A in 2016
Manhuadao is an online platform dedicated to comic book reading and community engagement. It offers a diverse selection of comics across various genres, including original works from emerging comic artists. The platform not only serves as a repository for comic series but also fosters interaction among comic enthusiasts through its community forum. Manhuadao aims to build a comprehensive animation industry chain by collaborating with enterprises across multiple sectors, including novels, comics, animation, film, television, and gaming. By creating a fun and interactive environment, the company enhances the overall experience for comic fans while promoting non-commercial sharing and communication within its community.

OrigiMed

Angel Round in 2016
OrigiMed Inc. is a Shanghai-based company that specializes in research and clinical support services for cancer patients. It focuses on developing innovative technologies and clinical applications aimed at improving cancer treatment outcomes. By employing comprehensive high-throughput methods and extensive bioinformatics analysis, OrigiMed identifies cancer-specific molecular markers and genomic features. This information is essential for guiding targeted therapies and immunotherapies. The company is committed to advancing precision medicine in cancer care, ultimately enhancing treatment options and effectiveness for patients in China.

CreditX

Series A in 2016
CreditX is a provider of financial services. They offer machine learning, finance risk management, big data analysis, and finance consulting services. Intelligent risk control, intelligent transaction monitoring, customer management, and intelligent customer service are among its business fields.

Shebaotong

Series A in 2016
Shebaotong provides social security, provident fund, commercial insurance, salary services, labor cost optimization and other services.

Geek+

Series A in 2016
Geek+ is a developer of autonomous mobile robots aimed at enhancing automation in warehouses, factories, and supply chain management. The company leverages advanced robotics and artificial intelligence technologies to offer flexible and intelligent logistics solutions tailored to various industries, including e-commerce, retail, logistics, pharmaceuticals, and manufacturing. Geek+ has established itself as a leader in the logistics robotics market in China, having delivered a significant number of robots compared to its competitors. Its clientele includes e-commerce platforms, third-party logistics providers, and manufacturers across diverse sectors such as apparel, electronics, and automotive. Additionally, Geek+ collaborates with key customers to co-create customized AI and robotic solutions, ensuring that they meet specific operational needs while providing reliable products and high-quality after-sales services.

Anjie IOT

Venture Round in 2016
Anjie IoT is a technological innovation firm specializing in the development of Internet of Things (IoT) solutions for utilities management. The company focuses on energy safety and economic solutions across various sectors, including public infrastructure. Anjie IoT's technology allows for the monitoring of the usage and condition of essential systems, such as air conditioning, electricity, fire protection, and building security. This capability enhances the efficiency of maintenance tasks, contributing to improved operational effectiveness. Emphasizing the principles of carbon peaking and carbon neutrality, Anjie IoT is committed to advancing the industry through science and technology while supporting national interests. As a high-tech enterprise and a member of the International Fog Computing Alliance, Anjie IoT is positioned at the forefront of innovation in the IoT space.

Xiaodupi

Series B in 2015
Xiaodupi is a developer of mobile applications focused on social engagement and personal development for younger audiences. The company's notable product is the Little Belly app, a weight loss application that leverages health technology to synchronize user weight data and provide personalized weight loss plans. Additionally, Xiaodupi has created a social media and gaming platform designed for girls under fourteen, which gamifies career learning and social development. This platform encourages interaction by offering virtual fashion items as incentives, fostering an engaging environment for its users. Through these applications, Xiaodupi aims to combine health management and social interaction in innovative ways.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.